Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in:  Forbes

Forbes reporter covering science and medicine

Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients

forbes.com — Last night, a panel of advisors to the Food and Drug Administration voted 7 to 3, with 3 abstentions, that the agency should not approve eteplirsen, a drug for a Duchenne muscular dystrophy, a rare, deadly, muscle-destroying disease, developed by Sarepta, a Cambridge, Mass-based biotechnology firm. (On another vote, which [...]

The CDC Says America's Suicide Rate Is Rising Dramatically

forbes.com — The rate of death by suicide in America has risen dramatically over the past 15 years, according to data released this morning by the Centers for Disease Control & Prevention. In 1999, 10.5 of every 100,000 people committed suicide. In 2014, that number had increased 24% to 13 out of every [...]

The FDA's Muscular Dystrophy Debacle Shows Trying To Speed Drugs Approvals Up Can Slow Them Down

forbes.com — Monday is likely to be a sad day. An experimental drug to treat some boys with Duchenne muscular dystrophy will be evaluated by a panel of experts convened by the Food and Drug Administration. Based on briefing documents made available by the FDA this morning, it looks very likely they [...]

What A Toddler And Her Tumor Can Teach Us About Cancer Research

forbes.com — The story of a 21-month-old baby in Florida named Carina, published in a medical journal today, provides an important reminder about cancer research -- that we have to play a long game and not just get obsessed with the latest thing. Carina (her parents don't want her last name printed) was [...]

Despite The Glitz, Sean Parker's Cancer Institute Could Be Something Special

forbes.com — Sean Parker Photographer: Simon Dawson/Bloomberg Earlier this week, Sean Parker, the billionaire known for co-founding Napster and serving as Facebook's first president, announced that he was donating $250 million -10% of his estimated net worth - to create a new institute to catalyze the development of cancer treatments that harness the [...]

Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging

forbes.com — A brilliant Turkish-American billionaire thinks he can heal arthritis, cure baldness and erase wrinkles. And that's just the start, as he aims to reverse the aging process itself.

Outside Experts Hired By Theranos See Promise But Still Seek Proof

forbes.com — Elizabeth Holmes speaks at the Forbes Healthcare Summit last December. Theranos, the embattled blood testing startup that hopes to replace needles with finger pricks, announced yesterday that it had recruited six experts in the science of diagnostic testing to its scientific advisory board, a group of paid consultants whose job is [...]

Allergan Boss Brent Saunders On The Failed Pfizer Deal And Why He's Not Like Valeant

forbes.com — Allergan CEO Brent Saunders Well, that's quite a monkey wrench. Two days ago, Allergan was set to be purchased by larger rival Pfizer in the largest pharmaceutical deal ever and its chief executive, Brent Saunders, looked as if he would be the heir apparent at Pfizer. But new rules from the [...]

Merck CEO Ken Frazier Is Looking Smart For Avoiding A Tax Inversion

forbes.com — Kenneth Frazier, chief executive officer of Merck & Co. Photographer: Chris Goodney/Bloomberg The U.S. Department of Treasury appears to have scuttled Pfizer's planned merger with Allergan, a "tax inversion" deal that would have lowered Pfizer's tax rate by letting it avoid U.S. taxes. It's a blow to Pfizer boss Ian Read, who dedicated a lot of [...]

The Treasury Tries To Stop Pharma's Tax Dodge

forbes.com — Most experts in corporate taxes thought there was little President Barack Obama could do to force Pfizer, the largest drug company in the U.S., from moving its corporate address to Dublin, Ireland, in order to escape paying American taxes. Yesterday evening, Jack Lew, Obama's secretary of the treasury, called Pfizer's bluff, instituting [...]
More Articles →
Apr 30, 2016

RT @AllenFrancesMD: Dumbest decision ever was FDA approval of female Viagra; here is smart critique showing how greed trumped need. https:/twitter.com/eloder/status/…t.co/1gK8i7UJL8

Apr 29, 2016

RT @JohnCFierce: First the WaPo opinion page endorses eteplirsen; now it's the WSJ op/ed page.Interesting major league pressure/$SRPT httpswsj.com/articles/menta…//t.co/bLmPSarFe9

Apr 29, 2016

RT @ddiamond: A source says investigators are "99% sure" Prince died from an accidental opioid overdose. theguardian.com/music/2016/apr…

Apr 29, 2016

RT @AndyBiotech: $IMGN also reported today that the ORR has dropped from 35% to below 30% for the full cohort. twitter.com/AndyBiotech/st…

Apr 29, 2016

RT @redacre: $IBB US FDA needs to be able to communicate to the public like this about CRLs ema.europa.eu/docs/en_GB/doc… H/T @AndyBiotech cc:@matthewherpertthewherper

Apr 29, 2016

RT @ByJonGardner: Didn't cover that story at #ECC2015 because I'd never heard of the company or the technology. #doh ow.ly/4neelh $ABBV

Apr 29, 2016

@MudsharkOX typo. Not clear how much aggregate drug spending reduces illness or costs.

Apr 29, 2016

@ddiamond @ASlavitt wait a second, Dan, why are you up? I am in London and its morning. You must sleep, man.


Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.